References
- Adam, E., J.L. Melnick, J.L. Probtsfield, B.L. Petrie, J. Burek, K.R. Bailey, C.H. McCollum, and M.E. DeMakey. 1987. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2, 291-293
- Adam, E., J.L. Melnick, and M.E. DeBakey. 1997. Cytomegalovirus infection and atherosclerosis. Cent. Eur. J. Public. Health 5, 99-106
- Andreasen, J.J., S. Farholt, and J.S. Jensen. 1998. Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. APMIS 106, 717-720
- Bloemenkamp, D.G., W.P. Mali, F.L.Visseren, and Y. van der Graaf. 2003. Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?. Am. Heart. J. 145, 409-417 https://doi.org/10.1067/mhj.2003.20
- Castresana, J. 2000. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol. Biol. Evol. 17, 540-552
- Chenna, R., H. Sugawara, T. Koike, R. Lopez, T.J. Gibson, D.G. Higgins, and J.D. Thompson. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31(13), 3497-3500
- Daus, H., C. Ozbek, D. Saage, B. Scheller, H. Schieffer, M. Pfreundschuh, and A. Gause. 1998. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90, 83-88
- Felsenstein, J. 1985. PHYLIP-Phylogeny Inference Package (Version 3.2). Cladistics 5, 164-166
- Grayston, J.T., C.C. Kuo, A.S. Coulson, L.A. Campbell, R.D. Lawrence, M.J. Lee, E.D. Strandness, and S.P. Wang. 1995. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92, 3397-3400
- Hajjar, D.P. 1991. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. Am. J. Pathol. 139, 1195-1211
- Hendrix, M.G., M.M. Salimans, C.P. van Boven, and C.A. Bruggeman. 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136, 23-28
- Jackson, L.A., L.A. Campbell, C.C. Kuo, D.I. Rodriguez, A. Lee, and J.T. Grayston. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176, 292-295.
- Jander, S., M. Sitzer, R. Schumann, M. Schroeter, M. Siebler, H. Steinmetz, and G. Stoll. 1998. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29, 1625-1630
- Kuvin, J.T. and C.D. Kimmelstiel. 1999. Infectious causes of atherosclerosis. Am. Heart. J. 137, 216-226
- Laitinen, K., A. Laurila, L. Pyhala, M. Leinonen, and P. Saikku. 1997. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect. Immun. 65, 4832-4835
- Lee, S.H. and S.J. Kim. 2002. Detection of infectious enteroviruses and adenoviruses un tap water in urban areas in Korea. Water Research 36, 248-256
- Libby, P. and M. Aikawa. 1998. New insights into plaque stabilisation by lipid lowering. Drugs 56 (Suppl 1), 9-13
- Lindholt, J.S., L. Ostergard, E.W. Henneberg, H. Fasting, and P. Andersen. 1998. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur. J. Vasc. Endovasc. Surg. 15, 161-164
- Maass, M., E. Krause, P.M. Engel, and S. Kruger. 1997. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 48, 699-706
- Mendall, M.A., P. Patel, L. Ballam, D. Strachan, and T.C. Northfield. 1996. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312, 1061-1065
- Muhlestein, J.B., J.L. Anderson, E.H. Hammond, L. Zhao, S. Trehan, E.P. Schwobe, and J.F. Carlquist. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97, 633-636
- Page, R.D.M. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12, 357-358
- Paget, C.J., S.W. Wolk, W.M. Whitehouse, E.E. Erlandson, R.M. Lampman, J. Schaldenbrand, and W.J. Fry. 1997. Incidence and pathophysiologic significance of infected carotid artery plaque. Ann. Vasc. Surg. 11, 129-132
- Paterson, D.L., J. Hall, S.J. Rasmussen, and P. Timms. 1998. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 30, 169-172 https://doi.org/10.1080/00313029800169166
- Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809
- Saetta, A., G. Fanourakis, E. Agapitos, and P.S. Davaris. 2000. Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol. 9, 181-183
- Saikku, P. 2000. Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more. J. Infect. Dis 181(Suppl 3), S41-413
- Shor, A., C.C. Kuo, & D.L. Patton. 1992. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82, 158-161
- Sohal, R.S., G.E. Burch, K.C. Chu, E. Leiderman, and H.L. Colcolough. 1968. Ultrastructural changes in cardiac capillaries of Coxsackie virus B4-infected mice. Lab. Invest. 19, 399-405
- Virchow, R. 1999. Phlogose und Thrombose in Gefassystem, gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt-am-Main: Meidinger Sohn; 1856. p. 458, cited in Kuvin JT, Kimmelstiel CD. Infectious causes of atherosclerosis. Am. Heart. J. 137, 216-226
- Yamashita, K., K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa, and H. Ito. 1998. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. 77 Stroke 29, 773-778
- Yonemitsu, Y., K. Komori, K. Sueishi, and K. Sugimachi. 1998. Possible role of cytomegalovirus infection in the pathogenesis of human vascular diseases. Nippon Rinsho 56, 102-108